期刊文献+

前列腺癌去雄激素治疗后的代谢并发症

下载PDF
导出
摘要 前列腺癌是男性老年多发病,确诊患者的中位年龄为72岁,高峰年龄为75~79岁。大多数前列腺癌的生物学行为呈惰性状态,进展较缓慢,所以确诊为前列腺癌的患者,其中大多数病例的预期寿命并不会因其而改变。由于前列腺癌患者有相对较长的癌特异生存期,目前关于根治性前列腺切除术、放射治疗及内分泌疗法等各种治疗方法的不良反应及可能发生的并发症,已越来越被人们重视。
作者 陈梓甫
出处 《现代泌尿生殖肿瘤杂志》 2012年第5期317-318,共2页 Journal of Contemporary Urologic and Reproductive Oncology
  • 相关文献

参考文献15

  • 1Lu Yao G, Stukel TA, Yao Sir. Changing patterns in compe- ting causes of death in men with prostate cancer:a population based study[J]. J Urol,2004,171(6 Pt 1):2285-2290.
  • 2Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity:a new category of obesity in the elderly[J]. Nutr Metab Card- iovsc Dis,2008,18(5) :388-395.
  • 3Smith MR, Finkelstein JS, Mcgoven FJ, et al. Changes in body composition during androgen deprivation therapy for prostate eancer[J]. J Clin Endocrinol Metab,2002,87(2) :599-603.
  • 4Smith MR. Changes in fat and lean body mass during andro gen deprivation therapy for prostate cancer[J]. Urology, 2004,63(4) : 742-745.
  • 5Segal RJ, Reid RD, Coumeya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer[J]. J Clin Oneol,2003,21(9) ;1653-1659.
  • 6徐久平,于德新,华和园,邹建安,陈久发.手术去势对前列腺癌患者血脂代谢的影响[J].临床泌尿外科杂志,2011,26(6):437-440. 被引量:5
  • 7Smith JC, Bennett S, Evans LM, et al. The effects of in duced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer[J]. J Clin Endocrinol Metab, 2001,86 (9):4261-4267.
  • 8Dockery F, Bulpitt CJ, Agarwal S, et al. Testosterone sup pression in men with prostate cancer leads to an increase in ar- terial stiffness and hyperinsulinaemia[J]. Clin Sei, 2003,104 (2):195 -201.
  • 9Smith MR, Lee H, Nathan DM. Insulin sensitivity during con,- bined androgen blockade for prostate cancer[J]. J Clin Endocrinol Metab, 2006,91 (4): 1305-1308.
  • 10华和园,于德新,徐久平,陈久发.手术去势对前列腺癌患者胰岛素抵抗及释放节律的影响[J].临床泌尿外科杂志,2011,26(1):14-16. 被引量:3

二级参考文献38

  • 1邱智,孙玉成,邵强,张弋,杜林栋.前列腺癌患者去势术后的睾酮水平[J].中华泌尿外科杂志,2006,27(2):125-127. 被引量:13
  • 2李江源,李小鹰,李明,张高魁,马芳玲,刘志明,张南雁,孟萍.年龄依赖性胰岛素抵抗与睾酮水平的相关性[J].中华老年医学杂志,2007,26(2):104-106. 被引量:8
  • 3Lu-Yao G,Stukel T A,Yao S L.Changing patterns in competing causes of death in men with prostate cancer:a population based study[J].J Urol,2004,171(6):2285-2290.
  • 4Xu T,Wang X,Hou S,et al.Effect of surgical castration on risk factors for arteriosclerosis of patients with prostate cancer[J] Chin Med J (Engl).2002,115(9):1336-1340.
  • 5Abate N,Haffner S M,Garg A,et al Sexsteroid hormones,upper body obesity,and insulin resistance[J].J Clin Endocrinol Metab,2002,87 (10):4522 -4527.
  • 6Basaria S.Muller D C,Carducci M A,et al.Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy[J].Cancer,2006.106(3):581-588.
  • 7Betancourt-Albrecht M,Cunningham G R.Hypogonadism and diabetes[J].Int J Impotence Res,2003,15(Suppl 4):S14-S20.
  • 8Lin BJ.Chen K K,Chen M T,et aL.The time for serum testosterone to reach castrate level after bilateral orchidectomy or oral estrogen in the managenment of metastatic prostate cancer[J].J Urol,1994,43:834-837.
  • 9Barter P. Metabolic abnormalities high-density lipopro teins[J]. Endocrinol Metab Clin North Am, 2004, 33 (2) : 393-403.
  • 10Malkin C J, Pugh P J, Jones R D, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profile in hypogonadal men[J]. JClin Endocrinol Metab, 2004, 89.. 3313--3318.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部